Bioengineered T cells for Leukaemia and Lymphoma
Cancer immunotherapy is a promising tool for treatment of malignancies. However, there are still hindrances that need to be overcome. Chimeric antigen receptors have the ability to direct immune cytotoxic cells towards tumour-associated antigens in major histocompatibility complex-independent manner...
| Main Author: | |
|---|---|
| Format: | Others |
| Language: | English |
| Published: |
Högskolan i Skövde, Institutionen för vård och natur
2011
|
| Online Access: | http://urn.kb.se/resolve?urn=urn:nbn:se:his:diva-5593 |